Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: Implications for posttransplant survival
- 30 April 2008
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 36 (4) , 464-472
- https://doi.org/10.1016/j.exphem.2007.12.010
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirusExperimental Hematology, 2007
- Regulation of hematopoiesis in vitro and in vivo by invariant NKT cellsBlood, 2006
- A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillanceThe Journal of Experimental Medicine, 2005
- NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogsJournal of Clinical Investigation, 2005
- To be or not to be NKT: Natural killer T cells in the liverHepatology, 2004
- Disseminated Varicella Infection Due to the Vaccine Strain of Varicella‐Zoster Virus, in a Patient with a Novel Deficiency in Natural Killer T CellsThe Journal of Infectious Diseases, 2003
- Hematopoietic stem cell graft manipulation as a mechanism of immunotherapyInternational Immunopharmacology, 2003
- Bone Marrow NK1.1− and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host DiseaseThe Journal of Experimental Medicine, 1999
- CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant Vα24JαQ T Cell Receptor α ChainsThe Journal of Experimental Medicine, 1998
- In vitro and in vivo analysis of bone marrow-derived CD3+, CD4−, CD8−, NK1.1+ cell linesCellular Immunology, 1990